StockNews.com Upgrades Cidara Therapeutics (NASDAQ:CDTX) to “Sell”

Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) was upgraded by equities researchers at StockNews.com to a “sell” rating in a research report issued on Friday. Other equities research analysts have also recently issued reports about the company. Cantor Fitzgerald upgraded Cidara Therapeutics to a “strong-buy” rating in a research note on Wednesday, February 5th. Needham […]